The Valens Company

The Valens Company with Everett Knight EVP, Corporate Development & Capital Markets. Our next guest works at the largest publicly traded extraction company in the world with a broad expanding international footprint. HealthEuropa recently described The Valens Company as “one of the few companies in the world that can facilitate the utilization of five extraction techniques using customized and proprietary methods and technology, with further research and development always ongoing. This flexibility and technical expertise allow The Valens Company to produce almost any cannabis product imaginable, which means its clients can make their vision of a unique and differentiated cannabis-infused product a reality”. When talking about building a brand, our guest believes the main goal for any company is to achieve profitability. Everett said this about what was attributed to Valens’ success in achieving profitability. Everett’s team recently announced its participation in a Medical Cannabis Real-World Evidence Study (the “MC-RWE Study”) led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada.

The Valens Company

The study will explore the therapeutic effects of medical cannabis in adults with chronic pain, sleep, or anxiety issues, and will leverage the blockchain secure technology of the Medical Cannabis by Shoppers online product portal of both tested and verified cannabis products. As part of the study, the Valens Company Nūance line of THC and CBD oils will be tested, with the verified results on each batch made available through the Medical Cannabis portal for each physician and patient. Patients will be able to identify the contents of their product through the platform, including potency levels of THC and CBD, and confidently rely on the data to ensure batch-to-batch consistency and quality. We talk about all that and so much more today on Blunt Business.